135 related articles for article (PubMed ID: 27678127)
21. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
[TBL] [Abstract][Full Text] [Related]
22. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
[TBL] [Abstract][Full Text] [Related]
23. Delayed Intravenous Thrombolysis in Patients with Minor Stroke.
Yoo J; Sohn SI; Kim J; Ahn SH; Lee K; Baek JH; Kim K; Hong JH; Koo J; Kim YD; Kwak J; Nam HS; Heo JH
Cerebrovasc Dis; 2018; 46(1-2):52-58. PubMed ID: 30092583
[TBL] [Abstract][Full Text] [Related]
24. Pharmacist Participation in Acute Ischemic Stroke Decreases Door-to-Needle Time to Recombinant Tissue Plasminogen Activator.
Rech MA; Bennett S; Donahey E
Ann Pharmacother; 2017 Dec; 51(12):1084-1089. PubMed ID: 28759998
[TBL] [Abstract][Full Text] [Related]
25. Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach.
Rostanski SK; Shahn Z; Elkind MSV; Liberman AL; Marshall RS; Stillman JI; Williams O; Willey JZ
Stroke; 2017 Jul; 48(7):1980-1982. PubMed ID: 28536170
[TBL] [Abstract][Full Text] [Related]
26. Endovascular stroke treatment does not preclude high thrombolysis rates.
Feda S; Nikoubashman O; Schürmann K; Matz O; Tauber SC; Wiesmann M; Schulz JB; Reich A
Eur J Neurol; 2019 Mar; 26(3):428-e33. PubMed ID: 30317687
[TBL] [Abstract][Full Text] [Related]
27. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
[TBL] [Abstract][Full Text] [Related]
28. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
[TBL] [Abstract][Full Text] [Related]
29. Treatment Delays for Patients With Acute Ischemic Stroke in an Iranian Emergency Department: A Retrospective Chart Review.
Hassankhani H; Soheili A; Vahdati SS; Mozaffari FA; Fraser JF; Gilani N
Ann Emerg Med; 2019 Feb; 73(2):118-129. PubMed ID: 30318375
[TBL] [Abstract][Full Text] [Related]
30. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
[TBL] [Abstract][Full Text] [Related]
31. Impact of CT scanner location on door to imaging time for emergency department stroke evaluation.
Bonadio W; Beck C; Mueller A
Am J Emerg Med; 2020 Feb; 38(2):309-310. PubMed ID: 31488337
[TBL] [Abstract][Full Text] [Related]
32. Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min.
Sablot D; Ion I; Khlifa K; Farouil G; Leibinger F; Gaillard N; Laverdure A; Bensalah ZM; Mas J; Fadat B; Smadja P; Ferraro-Allou A; Bonnec JM; Olivier N; Dutray A; Tardieu M; Dumitrana A; Guibal A; Jurici S; Bertrand JL; Allou T; Arquizan C; Bonafe A
Cerebrovasc Dis; 2018; 45(5-6):245-251. PubMed ID: 29843148
[TBL] [Abstract][Full Text] [Related]
33. Higher prehospital blood pressure prolongs door to needle thrombolysis times: a target for quality improvement?
Navalkele DD; Cai C; Vahidy F; Rahbar MH; Pandurengan R; Wu TC; Sarraj A; Barreto A; Grotta JC; Gonzales N
Am J Emerg Med; 2016 Jul; 34(7):1268-72. PubMed ID: 27139258
[TBL] [Abstract][Full Text] [Related]
34. Utilization of emergency medical service increases chance of thrombolytic therapy in patients with acute ischemic stroke.
Hsieh MJ; Tang SC; Chiang WC; Huang KY; Chang AM; Ko PC; Tsai LK; Jeng JS; Ma MH
J Formos Med Assoc; 2014 Nov; 113(11):813-9. PubMed ID: 24296308
[TBL] [Abstract][Full Text] [Related]
35. Role of Bedside Preparation in Reducing "Door-to-Needle" Tissue-Type Plasminogen Activator (Alteplase) Administration Times and Association with Patient Outcomes.
Lebahn KK; Waybright RA; Ngorsuraches S; Johnson TJ
S D Med; 2018 Sep; 71(9):416-421. PubMed ID: 30308121
[TBL] [Abstract][Full Text] [Related]
36. Simple text-messaging intervention is associated with improved door-to-needle times for acute ischemic stroke.
Burnett MM; Zimmermann L; Coralic Z; Quon T; Whetstone W; Kim AS
Stroke; 2014 Dec; 45(12):3714-6. PubMed ID: 25352486
[TBL] [Abstract][Full Text] [Related]
37. Identification of Rate-Limiting Steps in the Provision of Thrombolytics for Acute Ischemic Stroke.
Metts EL; Bailey AM; Weant KA; Justice SB
J Pharm Pract; 2017 Dec; 30(6):606-611. PubMed ID: 27834297
[TBL] [Abstract][Full Text] [Related]
38. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
[TBL] [Abstract][Full Text] [Related]
39. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal.
Nepal G; Yadav JK; Basnet B; Shrestha TM; Kharel G; Ojha R
BMC Neurol; 2019 Jul; 19(1):155. PubMed ID: 31288770
[TBL] [Abstract][Full Text] [Related]
40. Observational Multicenter Study of a Direct-to-CT Protocol for EMS-transported Patients with Suspected Stroke.
Cone DC; Cooley C; Ferguson J; Harrell AJ; Luk JH; Martin-Gill C; Marquis SW; Pasichow S
Prehosp Emerg Care; 2018; 22(1):1-6. PubMed ID: 28841085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
